Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 10, 2025 03:00 ET | Source: Vect-Horus

Secarna Pharmaceuticals et Vect-Horus annoncent un programme de recherche pour le transport ciblé des thérapies visant l’ARN pour traiter les maladies du système nerveux central.

Ce partenariat permet d'associer la technologie OligoCreator® de Secarna avec la plateforme VECTrans® de Vect-Horus, afin de rendre possible le transport systémique des oligonucléotides à travers la...
July 10, 2025 03:00 ET | Source: Vect-Horus

Secarna Pharmaceuticals and Vect-Horus Announce Research Collaboration to Advance Systemic Delivery of RNA-Targeted Therapeutics for CNS Disorders

The partnership combines Secarna’s OligoCreator® technology with Vect-Horus’ VECTrans® platform to enable systemic delivery of oligonucleotide therapies across the blood-brain barrierThis...
December 03, 2024 09:00 ET | Source: Weaviate

Weaviate Launches Flexible Embedding Service for AI Development

AMSTERDAM, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Weaviate’s latest SaaS service is bringing freedom and flexibility to a crucial area of AI development: data vectorization. Launched today, Weaviate...
September 27, 2023 16:00 ET | Source: Custom Market Insights

[Latest] Global Hemophilia B Gene Therapy Market Size/Share Worth USD 5,938.5 Billion by 2032 at a 34.1% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)

Austin, TX, USA, Sept. 28, 2023 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Hemophilia B Gene Therapy Market Size, Trends and Insights By Treatment Type...
November 16, 2022 07:00 ET | Source: SPHERICAL INSIGHTS LLP

Global Lentiviral Vectors Market Size to grow USD 829 Million by 2030 | CAGR of 18.5%

New York, United States , Nov. 16, 2022 (GLOBE NEWSWIRE) -- The Global lentiviral Vectors Market Size to grow from USD 180 million in 2021 to USD 829 million by 2030 at a Compound Annual Growth Rate...